샘플 요청 목록

 카트 문의
시장보고서
상품코드
1784018

세계의 POC(Point-Of-Care) 혈당 검사 시장

Point-of-Care Glucose Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 201 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

POC(Point-Of-Care) 혈당 검사 세계 시장은 2030년까지 41억 달러에 달할 전망

2024년에 34억 달러로 추정되는 POC(Point-Of-Care) 혈당 검사 세계 시장은 2024년부터 2030년까지 CAGR 3.3%로 성장하여 2030년에는 41억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 Accu Check Aviva Meter는 CAGR 4.1%를 기록하며 분석 기간 종료시에는 11억 달러에 달할 것으로 예측됩니다. Onetouch Verio Flex 부문의 성장률은 분석 기간 동안 CAGR 3.6%로 추정됩니다.

미국 시장은 9억 1,650만 달러로 추정, 중국은 CAGR 6.4%로 성장 예측

미국의 POC(Point-Of-Care) 혈당 검사 시장은 2024년에 9억 1,650만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 8억 1,940만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.5%로 예측됩니다. 유럽에서는 독일이 CAGR 1.9%로 성장할 것으로 예측됩니다.

세계의 POC(Point-Of-Care) 혈당 검사 시장 - 주요 동향과 촉진요인 정리

현장 혈당 측정이 당뇨병 관리에 필수적인 이유는 무엇인가?

POC(Point-Of-Care) 혈당 검사는 당뇨병 관리, 응급의료, 중환자 치료 현장에서 중요한 역할을 하며, 의료진과 환자가 실시간으로 치료 방침을 결정할 수 있는 혈당 수치를 즉각적으로 측정합니다. PoC 혈당 측정기는 시료 처리 시간이 필요한 기존 실험실 기반 혈당 검사와 달리 병원, 진료소, 외래 환자, 심지어 가정 환경에서도 현장에서 신속하게 혈당을 모니터링할 수 있습니다.

전 세계적으로 당뇨병 유병률의 증가는 POC 혈당 검사의 채택을 촉진하는 주요 요인 중 하나입니다. 국제당뇨병연맹(IDF)에 따르면, 전 세계적으로 5억 3,700만 명 이상의 성인이 당뇨병을 앓고 있으며, 이 숫자는 향후 몇 년 동안 크게 증가할 것으로 예상됩니다. 효과적인 혈당 모니터링과 혈당 조절은 저혈당, 케톤산증, 심혈관질환과 같은 합병증을 예방하는 데 매우 중요하며, PoC 혈당 검사는 일상적인 당뇨병 치료의 필수적인 부분이 되었습니다.

자가 혈당 측정(SMBG) 장치와 연속 혈당 모니터링(CGM) 시스템의 채택이 증가함에 따라 당뇨병 환자는 혈당 수치를 자주 추적하고 그에 따라 생활습관 및 약물 치료를 조정할 수 있습니다. 또한 병원과 응급실은 저혈당 및 고혈당을 신속하게 감지하여 즉각적인 치료 개입과 환자 결과 개선을 보장하기 위해 PoC 혈당 측정기에 의존하고 있습니다.

기술 발전은 POC 혈당 검사를 어떻게 개선하고 있는가?

POC 혈당 검사 시장은 바이오센서 기술, 커넥티드 솔루션, 비침습적 혈당 모니터링 기술의 발전으로 빠르게 진화하고 있습니다.

가장 중요한 기술 혁신 중 하나는 무선 연결과 디지털 건강 솔루션의 통합입니다. 최신 PoC 혈당측정기는 블루투스, Wi-Fi, 모바일 앱 호환성을 갖추고 있으며, 전자 의료 기록(EHR), 클라우드 기반 플랫폼, 당뇨병 관리 애플리케이션으로 원활한 데이터 전송을 가능하게 합니다. 이 기능을 통해 원격 환자 모니터링(RPM) 및 의사와 환자의 협업이 가능해져 보다 적극적이고 효율적인 당뇨병 관리가 가능해집니다.

또 다른 획기적인 발전은 비침습적, 최소침습적 혈당 모니터링 기기의 개발입니다. 기존의 혈당 측정은 손가락을 찔러야 하기 때문에 환자에게 고통스럽고 불편합니다. 기업들은 현재 웨어러블 바이오센서, 땀을 이용한 혈당 감지, 적외선을 이용해 피부에서 혈당 수치를 측정하는 광학식 혈당 센서를 이용한 바늘 없는 혈당 모니터링에 주목하고 있습니다. 비침습적 혈당 검사는 환자의 순응도를 높이고 사용자 경험을 개선함으로써 당뇨병 관리에 혁명을 가져올 것으로 기대되고 있습니다.

지속적 혈당 모니터링(CGM) 시스템의 발전도 시장을 재편하고 있습니다. 일회성 측정값을 제공하는 기존 PoC 혈당 측정기와 달리 CGM은 트렌드 분석과 저혈당 또는 고혈당 경고를 통해 실시간 혈당 모니터링을 제공합니다. Abbott(FreeStyle Libre), Dexcom(G6 및 G7), Medtronic(Guardian Connect) 등 주요 제조업체들은 센서 장착 시간 연장, 정확도 향상, 인슐린 펌프와의 통합을 위해 CGM 기술을 지속적으로 개선하고 있습니다. 개선하고 있습니다.

또한, AI 기반 혈당 분석 및 예측 알고리즘은 혈당 모니터링의 정확도를 높이고 있습니다. 기계 학습 모델은 현재 혈당 추세를 분석하고, 변동성을 예측하고, 인슐린 투여, 식사 계획, 신체 활동 조정에 대한 개인화 된 권장 사항을 제공 할 수 있습니다. AI를 활용한 PoC 혈당 검사 솔루션은 합병증을 줄이고, 혈당 조절을 개선하며, 맞춤형 당뇨병 관리를 지원할 것으로 기대되고 있습니다.

POC 혈당 검사에 대한 수요가 의료 및 재택의료 현장에서 증가하는 이유는 무엇인가?

당뇨병, 대사 이상, 생활습관병의 유병률이 증가함에 따라 병원, 외래 진료소, 재택 간호 현장에서 POC 혈당 검사가 널리 채택되고 있습니다.

  • 병원 및 중환자실에서의 사용 : 중환자실(ICU), 응급실(ER), 수술 전후 치료에서 급성 혈당 사건의 신속한 진단 및 관리를 위해 POC 혈당 검사를 활용하고 있습니다. 수술, 외상 치료, 화학요법을 받는 환자는 혈당 수치가 변동하는 경우가 많으며, 합병증을 예방하기 위해 침대 옆에서 자주 혈당 모니터링을 해야 합니다.
  • 자가 모니터링 및 홈케어 : 집에서 당뇨병을 관리하는 사람들이 늘어남에 따라 자가 혈당 측정(SMBG) 기기에 대한 수요가 급증하고 있습니다. 보기 쉬운 디스플레이, 음성 지원 기능, 클라우드 기반 추적 기능을 갖춘 컴팩트하고 사용하기 쉬운 혈당 측정기는 특히 노약자나 시각 장애가 있는 환자들에게 가정에서의 혈당 측정을 더욱 편리하게 해줍니다.
  • 임신성 당뇨 모니터링 : 임신성 당뇨(GDM) 진단을 받은 임산부는 산모와 아기의 합병증을 예방하기 위해 빈번한 혈당 모니터링이 필요합니다. GDM의 조기 발견과 관리를 지원하기 위해 산모 관리에서 휴대용, 일회용, 무선 혈당 측정기의 채택이 증가하고 있습니다.
  • 스포츠 및 피트니스 애플리케이션 : 운동선수와 피트니스 애호가들은 운동 전후의 혈당 변동을 모니터링하기 위해 POC 혈당 검사 및 CGM을 사용하고 있습니다. 이러한 추세는 신진대사 건강 상태와 에너지 최적화에 대한 인사이트를 실시간으로 제공하는 웨어러블 글루코스 모니터에 대한 수요를 촉진하고 있습니다.

원격의료와 디지털 헬스 플랫폼의 확대도 POC 혈당 검사 솔루션의 수요 확대에 기여하고 있습니다. 현재 많은 원격의료 서비스 제공자들은 혈당 모니터링 데이터를 가상 진료와 통합하여 고위험군 환자의 원격 당뇨병 관리 및 조기 개입을 가능하게 하고 있습니다.

POC 혈당 검사 시장의 성장을 촉진하는 요인은 무엇인가?

POC 혈당 검사 시장의 성장은 기술 발전, 당뇨병 유병률 증가, 적극적인 건강 관리에 대한 소비자의 인식 증가로 인해 발생합니다.

  • 당뇨병 유병률 증가와 만성질환 부담 증가 : 전 세계적으로 당뇨병의 유행은 실시간 혈당 모니터링 솔루션에 대한 수요를 지속적으로 촉진하고 있습니다. 특히 아시아태평양, 라틴아메리카, 아프리카 등 신흥국에서는 당뇨병 환자가 급증하고 있으며, 각국 정부는 PoC 혈당 검사를 포함한 전국적인 당뇨병 검진 및 예방 프로그램 시행을 추진하고 있습니다.
  • 당뇨병 관리에 대한 정부 및 보험 지원 : 많은 국가에서 혈당 모니터링 기기에 대한 보험 적용 및 상환 정책을 확대하고 있으며, PoC 혈당 측정기 및 CGM은 당뇨병 환자가 더 쉽게 사용할 수 있게 되었습니다. FDA, EMA, WHO 등 의료 기관은 의료 성과를 개선하기 위해 커넥티드 혈당 측정기 및 AI 기반 당뇨병 관리 도구의 사용을 장려하고 있습니다.
  • 웨어러블 및 스마트 혈당 모니터링 기기 채택 증가 : 기존 혈당 측정기에서 스마트 CGM 및 바이오 센서로의 전환은 당뇨병 치료를 재편하고 있습니다. 특히 1형 당뇨병 환자나 인슐린 의존형 제2형 당뇨병 환자들 사이에서 자동 인슐린 투여 기능을 통합한 웨어러블 CGM에 대한 수요가 증가하고 있습니다.
  • 최소침습적이고 통증이 적은 검사 방법에 대한 수요 증가 : 비침습적 혈당 모니터링 솔루션은 환자들이 보다 통증이 적고 편리하며 지속적인 혈당 추적 옵션을 요구함에 따라 견인력을 높일 것으로 예상됩니다. 눈물, 땀, 타액 기반 혈당 검출에 대한 연구가 활발히 진행되고 있으며, 기업들은 차세대 비침습적 혈당 센서에 투자하고 있습니다.
  • AI와 데이터 분석의 부상 : AI를 활용한 예측 분석, 혈당 경향 예측, 맞춤형 당뇨병 코칭은 환자와 의료진이 혈당 관리를 하는 방식을 변화시키고 있습니다. PoC 혈당 검사 장비에 머신러닝 알고리즘을 통합함으로써 치료 의사결정을 최적화하고 당뇨병 관련 합병증을 줄일 수 있을 것으로 기대됩니다.

혈당 모니터링 기술의 지속적인 기술 혁신, 원격 환자 모니터링의 채택 확대, 의료 및 가정 환경에서의 적용 확대에 따라 POC 혈당 검사 시장은 비약적인 성장을 이룰 것입니다. 커넥티드 헬스 솔루션, AI 기반 진단, 환자 중심의 당뇨병 관리 전략이 발전함에 따라, PoC 혈당 검사는 전 세계적으로 개인화된 데이터 기반 헬스케어의 핵심이 될 것으로 보입니다.

부문

제품(Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, 기타)

조사 대상 기업 사례

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi S.A.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.11

Global Point-of-Care Glucose Testing Market to Reach US$4.1 Billion by 2030

The global market for Point-of-Care Glucose Testing estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Accu Check Aviva Meter, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Onetouch Verio Flex segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$916.5 Million While China is Forecast to Grow at 6.4% CAGR

The Point-of-Care Glucose Testing market in the U.S. is estimated at US$916.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$819.4 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Point-of-Care Glucose Testing Market - Key Trends & Drivers Summarized

Why Is Point-of-Care Glucose Testing Essential in Diabetes Management?

Point-of-care (PoC) glucose testing plays a crucial role in diabetes management, emergency care, and critical care settings, providing immediate blood glucose readings that enable healthcare providers and patients to make real-time treatment decisions. Unlike traditional laboratory-based glucose tests, which require sample processing time, PoC glucose meters allow for rapid, on-the-spot glucose monitoring in hospitals, clinics, ambulatory settings, and even home environments.

The global rise in diabetes prevalence is one of the major factors driving the adoption of PoC glucose testing. According to the International Diabetes Federation (IDF), over 537 million adults worldwide have diabetes, and this number is expected to grow significantly in the coming years. Effective glucose monitoring and glycemic control are critical in preventing complications such as hypoglycemia, ketoacidosis, and cardiovascular diseases, making PoC glucose testing an integral part of routine diabetes care.

The increasing adoption of self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems has empowered diabetic patients to track their glucose levels frequently and make lifestyle or medication adjustments accordingly. Additionally, hospitals and emergency departments rely on PoC glucose meters for rapid hypoglycemia and hyperglycemia detection, ensuring immediate therapeutic interventions and improved patient outcomes.

How Are Technological Advancements Improving PoC Glucose Testing?

The PoC glucose testing market is rapidly evolving with advancements in biosensor technology, connectivity solutions, and non-invasive glucose monitoring techniques.

One of the most significant innovations is the integration of wireless connectivity and digital health solutions. Modern PoC glucose meters are now equipped with Bluetooth, Wi-Fi, and mobile app compatibility, allowing seamless data transmission to electronic health records (EHRs), cloud-based platforms, and diabetes management applications. This feature enables remote patient monitoring (RPM) and physician-patient collaboration, making diabetes management more proactive and efficient.

Another breakthrough is the development of non-invasive and minimally invasive glucose monitoring devices. Traditional blood glucose testing requires finger-pricking, which can be painful and inconvenient for patients. Companies are now focusing on needle-free glucose monitoring using wearable biosensors, sweat-based glucose detection, and optical glucose sensors that utilize infrared light to measure glucose levels through the skin. Non-invasive glucose testing is expected to revolutionize diabetes management by enhancing patient adherence and improving user experience.

Advancements in continuous glucose monitoring (CGM) systems are also reshaping the market. Unlike traditional PoC glucose meters that provide single-time readings, CGMs offer real-time glucose monitoring with trend analysis and alerts for hypoglycemia or hyperglycemia. Leading manufacturers, such as Abbott (FreeStyle Libre), Dexcom (G6 and G7), and Medtronic (Guardian Connect), are continuously improving CGM technology to offer longer sensor wear, improved accuracy, and integration with insulin pumps.

Additionally, AI-driven glucose analytics and predictive algorithms are enhancing the precision of glucose monitoring. Machine learning models can now analyze glucose trends, predict fluctuations, and provide personalized recommendations for insulin dosing, meal planning, and physical activity adjustments. AI-powered PoC glucose testing solutions are expected to reduce complications, improve glycemic control, and support personalized diabetes management.

Why Is Demand for PoC Glucose Testing Growing Across Healthcare and Homecare Settings?

The increasing prevalence of diabetes, metabolic disorders, and lifestyle-related diseases has led to the widespread adoption of PoC glucose testing in hospitals, outpatient clinics, and homecare settings.

  • Hospital & Critical Care Use: Healthcare facilities utilize PoC glucose testing for rapid diagnosis and management of acute glycemic events in intensive care units (ICUs), emergency rooms (ERs), and perioperative care. Patients undergoing surgery, trauma care, or chemotherapy often experience fluctuations in blood glucose levels, necessitating frequent bedside glucose monitoring to prevent complications.
  • Self-Monitoring & Homecare: The demand for self-monitoring blood glucose (SMBG) devices has surged as more individuals manage diabetes independently at home. Compact, user-friendly glucose meters with easy-to-read displays, voice-assisted functions, and cloud-based tracking have made home-based glucose monitoring more convenient, particularly for elderly and visually impaired patients.
  • Gestational Diabetes Monitoring: Pregnant women diagnosed with gestational diabetes mellitus (GDM) require frequent glucose monitoring to prevent complications for both the mother and baby. The adoption of portable, disposable, and wireless glucose meters in prenatal care is increasing to support early detection and management of GDM.
  • Sports & Fitness Applications: Athletes and fitness enthusiasts are using PoC glucose testing and CGMs to monitor glucose variations before and after workouts. This trend has fueled demand for wearable glucose monitors that provide real-time insights into metabolic health and energy optimization.

The expansion of telemedicine and digital health platforms has also contributed to the growing demand for PoC glucose testing solutions. Many telehealth providers now integrate glucose monitoring data with virtual consultations, enabling remote diabetes management and early intervention for high-risk patients.

What Factors Are Driving the Growth of the PoC Glucose Testing Market?

The growth in the PoC glucose testing market is driven by technological advancements, increasing diabetes prevalence, and rising consumer awareness about proactive healthcare.

  • Rising Diabetes Prevalence & Chronic Disease Burden: The global diabetes epidemic continues to fuel demand for real-time glucose monitoring solutions. Developing countries, particularly in Asia-Pacific, Latin America, and Africa, are experiencing a surge in diabetes cases, prompting governments to implement nationwide diabetes screening and prevention programs that incorporate PoC glucose testing.
  • Government & Insurance Support for Diabetes Management: Many countries are expanding insurance coverage and reimbursement policies for glucose monitoring devices, making PoC glucose meters and CGMs more accessible to diabetic patients. Health agencies such as the FDA, EMA, and WHO are promoting the use of connected glucose meters and AI-driven diabetes management tools to improve healthcare outcomes.
  • Increased Adoption of Wearable & Smart Glucose Monitoring Devices: The transition from traditional glucose meters to smart CGMs and biosensors is reshaping diabetes care. The demand for wearable CGMs with automated insulin delivery integration is growing, particularly among Type 1 and insulin-dependent Type 2 diabetic patients.
  • Growing Demand for Minimally Invasive & Painless Testing Methods: Non-invasive glucose monitoring solutions are expected to gain traction as patients seek less painful, convenient, and continuous glucose tracking options. Research into tear, sweat, and saliva-based glucose detection is gaining momentum, with companies investing in next-generation non-invasive glucose sensors.
  • Rise of AI & Data Analytics in Diabetes Care: AI-driven predictive analytics, glucose trend forecasting, and personalized diabetes coaching are transforming how patients and healthcare providers manage blood sugar levels. The integration of machine learning algorithms into PoC glucose testing devices is expected to optimize treatment decisions and reduce diabetes-related complications.

With continuous innovations in glucose monitoring technology, increasing adoption of remote patient monitoring, and expanding applications in healthcare and home settings, the PoC glucose testing market is set for exponential growth. As connected health solutions, AI-driven diagnostics, and patient-centered diabetes management strategies evolve, PoC glucose testing will remain a cornerstone of personalized, data-driven healthcare worldwide.

SCOPE OF STUDY:

The report analyzes the Point-of-Care Glucose Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi S.A.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Point-of-Care Glucose Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Diabetes Epidemic and Focus on Glycemic Control Propel Demand for Rapid Point-of-Care Glucose Testing
    • Increased Use of POC Glucose Testing in Emergency Rooms and Acute Care Drives Market Expansion
    • Adoption of Bedside Glucose Monitoring in ICUs and Surgical Wards Enhances Patient Safety and Protocol Compliance
    • Home-Based Diabetes Management and Self-Monitoring Support Widespread Use of Compact POC Glucose Devices
    • Technological Innovation in Continuous and Intermittent Glucose Monitoring Blurs Lines With Traditional POC Devices
    • Integration of POC Glucose Test Results With EHR and Mobile Apps Enables Holistic Chronic Disease Management
    • Public Health Campaigns on Early Diabetes Screening Encourage Testing at Pharmacies and Primary Care Clinics
    • Demand for Rapid Testing in Low-Resource and Rural Areas Supports Use of Portable, Battery-Operated Devices
    • Advancements in Non-Invasive and Painless Glucose Testing Technologies Create Disruption Potential
    • Stricter Infection Control and Cross-Contamination Concerns Support Shift to Single-Use, Disposable Strips
    • Reimbursement Policies for POC Glucose Testing Drive Institutional Adoption Across Outpatient Settings
    • Retail Clinics and DTC Health Providers Expand Glucose Testing Accessibility Beyond Traditional Healthcare Facilities
    • Wearable and Smart Glucose Monitors Integrated With POC Capabilities Gain Traction Among Tech-Savvy Patients
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Point-of-Care Glucose Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Accu Check Aviva Meter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Onetouch Verio Flex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for i-STAT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Bayer Contour Blood Glucose Monitoring System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Freestyle Lite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for True Metrix by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Accu-Chek Inform II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for StatStrip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제